David Paterson is the Director of ADVANCE-ID (ADVANcing Clinical Evidence for Infectious Diseases) at the Saw Swee Hock School of Public Health and the Yong Loo Lin School of Medicine. ADVANCE-ID is a clinical trials network spanning more than 100 hospitals across 20 countries in Asia, supported by the Wellcome Trust and Singapore-based partners. The network conducts clinically relevant studies addressing antimicrobial resistance (AMR), including trials of antibiotics, diagnostics, and prevention strategies.
David also holds an Honorary Professorship at the University of Queensland and has authored over 600 peer-reviewed publications, mainly on AMR. His research concentrates on the molecular and clinical epidemiology of infections caused by antibiotic-resistant organisms, with a strong focus on translating findings into improved prevention and treatment. Multi-country clinical trials are the major component of his research portfolio, and the predominant focus of ADVANCE-ID.